Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age

View ORCID ProfileTimothy A. Bates, Pei Lu, Ye jin Kang, Devin Schoen, View ORCID ProfileMicah Thornton, View ORCID ProfileSavannah K. McBride, Chanhee Park, View ORCID ProfileDaehwan Kim, William B. Messer, Marcel E. Curlin, View ORCID ProfileFikadu G. Tafesse, Lenette L. Lu
doi: https://doi.org/10.1101/2022.08.12.22278726
Timothy A. Bates
1Department of Molecular Microbiology and Immunology, Oregon Health and Sciences University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothy A. Bates
Pei Lu
2Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ye jin Kang
2Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Devin Schoen
3Department of Occupational Health, Oregon Health and Sciences University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Micah Thornton
4Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Micah Thornton
Savannah K. McBride
1Department of Molecular Microbiology and Immunology, Oregon Health and Sciences University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Savannah K. McBride
Chanhee Park
4Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daehwan Kim
4Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daehwan Kim
William B. Messer
1Department of Molecular Microbiology and Immunology, Oregon Health and Sciences University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel E. Curlin
3Department of Occupational Health, Oregon Health and Sciences University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Lenette.Lu@UTSouthwestern.edu tafesse@ohsu.edu curlin@ohsu.edu
Fikadu G. Tafesse
1Department of Molecular Microbiology and Immunology, Oregon Health and Sciences University, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fikadu G. Tafesse
  • For correspondence: Lenette.Lu@UTSouthwestern.edu tafesse@ohsu.edu curlin@ohsu.edu
Lenette L. Lu
2Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
5Department of Immunology, UT Southwestern Medical Center, Dallas, TX
6Parkland Health & Hospital System
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Lenette.Lu@UTSouthwestern.edu tafesse@ohsu.edu curlin@ohsu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Each novel SARS-CoV-2 variant renews concerns about decreased vaccine efficacy caused by evasion of vaccine induced neutralizing antibodies. However, accumulating epidemiological data show that while vaccine prevention of infection varies, protection from severe disease and death remains high. Thus, immune responses beyond neutralization could contribute to vaccine efficacy. Polyclonal antibodies function through their Fab domains that neutralize virus directly, and Fc domains that induce non-neutralizing host responses via engagement of Fc receptors on immune cells. To understand how vaccine induced neutralizing and non-neutralizing activities synergize to promote protection, we leverage sera from 51 SARS-CoV-2 uninfected health-care workers after two doses of the BNT162b2 mRNA vaccine. We show that BNT162b2 elicits antibodies that neutralize clinical isolates of wildtype and five variants of SARS-CoV-2, including Omicron BA.2, and, critically, induce Fc effector functions. FcγRIIIa/CD16 activity is linked to neutralizing activity and associated with post-translational afucosylation and sialylation of vaccine specific antibodies. Further, neutralizing and non-neutralizing functions diminish with age, with limited polyfunctional breadth, magnitude and coordination observed in those ≥65 years old compared to <65. Thus, studying Fc functions in addition to Fab mediated neutralization provides greater insight into vaccine efficacy for vulnerable populations such as the elderly against SARS-CoV-2 and novel variants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by a grant from the M. J. Murdock Charitable Trust (to MEC), an unrestricted grant from the OHSU Foundation (to MEC), the NIH training grant T32HL083808 (to TAB), NIH grant R011R01AI141549-01A1 (to FGT), OHSU Innovative IDEA grant 1018784 (to FGT), NIH grant R01AI145835 (to WBM), Burroughs Wellcome Fund UT Southwestern Training Resident Doctors as Innovators in Science (to YJK), pilot project grant from the UT Southwestern Department of Internal Medicine and Disease Oriented Scholars Award (to LLL).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Review Board of Oregon Health & Science University gave ethical approval for this work (IRB#00022511)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The dataset generated during this study is available upon reasonable request. This paper does not report original code. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 16, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, Devin Schoen, Micah Thornton, Savannah K. McBride, Chanhee Park, Daehwan Kim, William B. Messer, Marcel E. Curlin, Fikadu G. Tafesse, Lenette L. Lu
medRxiv 2022.08.12.22278726; doi: https://doi.org/10.1101/2022.08.12.22278726
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
Timothy A. Bates, Pei Lu, Ye jin Kang, Devin Schoen, Micah Thornton, Savannah K. McBride, Chanhee Park, Daehwan Kim, William B. Messer, Marcel E. Curlin, Fikadu G. Tafesse, Lenette L. Lu
medRxiv 2022.08.12.22278726; doi: https://doi.org/10.1101/2022.08.12.22278726

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9772)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2312)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1561)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11649)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1179)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4661)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)